
U.S. and China Signal Trade Progress Ahead of Trump-Xi Meeting
WSJ What’s News
00:00
Novartis Acquires Avidity for Neuromuscular Drugs
Brief report on Novartis' $12 billion acquisition of Avidity to bolster treatments for muscular dystrophy.
Transcript
Play full episode


